by Biological seed treatment involves the application of biocontrol agents such as microbes and plant extracts on seeds to protect them from diseases, pests, and disorders. It helps control seed- and soil-borne diseases without using harmful chemicals. The increasing need to boost agricultural production while reducing pesticide use is propelling many farmers and growers to adopt biological seed treatments.
The global Biological Seed Treatment Market is estimated to be valued at US$ 1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends
The rising focus on enhancing crop yield without damaging the environment is one of the key factors driving the growth of the biological seed treatment market. Biological seed treatments help control diseases and optimize plant health without using harsh chemicals. They are easier on the environment and support more sustainable agricultural practices. With growing concerns about excessive chemical use and rise in organic farming, many farmers are shifting toward biological options to protect seed health. This increasing preference for environment-friendly products is expected to boost the demand for biological seed treatments over the forecast period.
SWOT Analysis
Strength: Biological seed treatment offers protection against various pests and diseases without using harmful chemicals. This makes biological seed treatment more environmentally sustainable compared to conventional chemical seed treatment methods.
Weakness: Biological seed treatment takes more time to take effect compared to chemical methods. It also requires proper storage and handling conditions.
Opportunity: Increasing consumer preference for organic foods and awareness about harmful effects of pesticides is driving demand for biological seed treatment products. Many government policies also promote use of biopesticides and biological methods over chemical ones.
Threats: High research and development costs involved in developing new biological crop protection products. Unexpected changes in weather and climate can also impact efficiency of certain biological agents.
Key Takeaways
The global Biological Seed Treatment Market Demand is expected to witness high growth. The global Biological Seed Treatment Market is estimated to be valued at US$ 1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
North America currently dominates the market due to rapid adoption of organic farming practices in the region. The US biological seed treatment market holds the largest share currently. The Asia Pacific region is expected to grow at the fastest pace during the forecast period owing to increasing population, rise in disposable incomes, and growing awareness about organic farming in countries like India and China. Favorable government policies are also promoting adoption of biopesticides over chemical pesticides in the Asia Pacific region.
Key players operating in the biological seed treatment market are Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
